Alpana Singh
Vidya Vihar Raebareli Road
Lucknow, UP 226025, India
Lucknow, UP 226025, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Pathobiology-guided diagnostic advances, biomarker discovery, and emerging therapeutic strategies in progressive multiple sclerosis.
Journal: Disease-a-month : DM
Published: August 21, 2026
Retraction Note: Chronic stress-mediated dysregulations in inflammatory, immune and oxidative circuitry impairs the therapeutic response of methotrexate in experimental autoimmune disease models.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: February 06, 2026
Danon disease: From genetic origins and molecular defects to therapeutic advances.
Journal: Disease-a-month : DM
Published: September 17, 2025
Bezafibrate, a Pan PPAR agonist, attenuates experimental rheumatoid arthritis via PPAR dependent modulation of inflammatory pathways with emphasis on PPAR γ activity.
Journal: International immunopharmacology
Published: August 06, 2025
VEXAS syndrome: A newly identified X-Linked hematoinflammatory disorder - A comprehensive overview of its genetic, molecular, inflammatory, and clinical landscape.
Journal: Journal of autoimmunity
Published: March 14, 2025
Potentials of peroxisome proliferator-activated receptor (PPAR) α, β/δ, and γ: An in-depth and comprehensive review of their molecular mechanisms, cellular Signalling, immune responses and therapeutic implications in multiple diseases.
Journal: International immunopharmacology
Published: January 22, 2025
Erdheim-Chester disease: Comprehensive insights from genetic mutations to clinical manifestations and therapeutic advances.
Journal: Disease-a-month : DM
Published: January 05, 2025
Effect of a Natural Surfactant (Fenugreek Seeds) on Emulsification and Mobilization of Paraffins via Pore-Scale Micromodel Experiments.
Journal: Langmuir : the ACS journal of surfaces and colloids
Published: August 15, 2024
Chronic stress-mediated dysregulations in inflammatory, immune and oxidative circuitry impairs the therapeutic response of methotrexate in experimental autoimmune disease models.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: June 19, 2024
Showing 1-9 of 9
Last Updated: 09/26/2026